{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:44:35Z","timestamp":1792565075842,"version":"4.5.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12935-z","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:14:08Z","timestamp":1792556048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathogenesis of steroid refractoriness in acute graft versus host disease"],"prefix":"10.1007","volume":"53","author":[{"given":"Mohammed","family":"Debes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abouzeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Aljrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Elyasaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"1","key":"12935_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41467-024-44703-7","volume":"15","author":"K Maas-Bauer","year":"2024","unstructured":"Maas-Bauer K, Stell A-V, Yan K-L, de Vega E, Vinnakota JM, Unger S et al (2024) ROCK1\/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease. Nat Commun 15(1):446","journal-title":"Nat Commun"},{"key":"12935_CR2","doi-asserted-by":"publisher","first-page":"641910","DOI":"10.3389\/fimmu.2021.641910","volume":"12","author":"X Xu","year":"2021","unstructured":"Xu X, Li X, Zhao Y, Huang H (2021) Immunomodulatory Effects of Histone Deacetylation Inhibitors in Graft-vs.-Host Disease After Allogeneic Stem Cell Transplantation. Front Immunol 12:641910","journal-title":"Front Immunol"},{"issue":"1","key":"12935_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s44337-025-00382-x","volume":"2","author":"M Debes","year":"2025","unstructured":"Debes M, Elyasaky A, Abouzeid M, Elantary R, Mahmood Z, Downey R et al (2025) The JAK1\/2 inhibitor Ruxolitinib as therapeutic option in steroid resistance, prophylaxis and frontline therapy for graft versus host disease, meta-analysis. Discover Med 2(1):178","journal-title":"Discover Med"},{"key":"12935_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fonc.2014.00089","volume":"4","author":"S Fuji","year":"2014","unstructured":"Fuji S, Kapp M, Einsele H (2014) Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Front Oncol 4:89","journal-title":"Front Oncol"},{"issue":"9","key":"12935_CR5","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.bbmt.2016.04.022","volume":"22","author":"AM Ali","year":"2016","unstructured":"Ali AM, DiPersio JF, Schroeder MA (2016) The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review. Biol Blood Marrow Transpl 22(9):1552\u20131564","journal-title":"Biol Blood Marrow Transpl"},{"key":"12935_CR6","doi-asserted-by":"publisher","unstructured":"Debes M, Athwal H, Elyasaky A, Abouzeid M, Mohammad I, Elantary R, Ali SM. Mesenchymal stromal cells in management of steroid refractory acute graft vesrus host disease, systematic review and meta-analysis. Sci Rep. 2025 Nov 22;15(1):44196. 10.1038\/s41598-025-27948-0. PMID: 41274979; PMCID: PMC12717112. https:\/\/doi.org\/10.1038\/s41598-025-27948-0","DOI":"10.1038\/s41598-025-27948-0"},{"issue":"8","key":"12935_CR7","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3324\/haematol.2020.253716","volume":"106","author":"S Cordes","year":"2021","unstructured":"Cordes S, Mokhtari Z, Bartosova M, Mertlitz S, Riesner K, Shi Y et al (2021) Endothelial damage and dysfunction in acute graft-versus-host disease. Haematologica 106(8):2147\u20132160","journal-title":"Haematologica"},{"issue":"2","key":"12935_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jsbmb.2010.02.018","volume":"120","author":"PJ Barnes","year":"2010","unstructured":"Barnes PJ (2010) Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol 120(2):76\u201385","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5\u20137","key":"12935_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.steroids.2005.02.006","volume":"70","author":"J Zhou","year":"2005","unstructured":"Zhou J, Cidlowski JA (2005) The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 70(5\u20137):407\u2013417","journal-title":"Steroids"},{"issue":"1","key":"12935_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","volume":"42","author":"S Ramamoorthy","year":"2016","unstructured":"Ramamoorthy S, Cidlowski JA, Corticosteroids (2016) Mechanisms of Action in Health and Disease. Rheum Dis Clin North Am 42(1):15\u201331 vii","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"12935_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.tips.2018.11.002","volume":"40","author":"RA Panettieri","year":"2019","unstructured":"Panettieri RA, Schaafsma D, Amrani Y, Koziol-White C, Ostrom R, Tliba O (2019) Non-genomic Effects of Glucocorticoids: An Updated View. Trends Pharmacol Sci 40(1):38\u201349","journal-title":"Trends Pharmacol Sci"},{"key":"12935_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1196\/annals.1366.002","volume":"1088","author":"JC Buckingham","year":"2006","unstructured":"Buckingham JC, John CD, Solito E, Tierney T, Flower RJ, Christian H et al (2006) Annexin 1, glucocorticoids, and the neuroendocrine-immune interface. Ann N Y Acad Sci 1088:396\u2013409","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"12935_CR13","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1530\/ERC-20-0489","volume":"28","author":"I Mayayo-Peralta","year":"2021","unstructured":"Mayayo-Peralta I, Zwart W, Prekovic S (2021) Duality of glucocorticoid action in cancer: tumor-suppressor or oncogene? Endocr Relat Cancer 28(6):R157\u2013r71","journal-title":"Endocr Relat Cancer"},{"key":"12935_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fendo.2017.00016","volume":"8","author":"K Scheschowitsch","year":"2017","unstructured":"Scheschowitsch K, Leite JA, Assreuy J (2017) New Insights in Glucocorticoid Receptor Signaling-More Than Just a Ligand-Binding Receptor. Front Endocrinol (Lausanne) 8:16","journal-title":"Front Endocrinol (Lausanne)"},{"key":"12935_CR15","doi-asserted-by":"publisher","unstructured":"Kumar R, Thompson EB. Role of Phosphorylation in the Modulation of the Glucocorticoid Receptor's Intrinsically Disordered Domain. Biomolecules. 2019 Mar 11;9(3):95. PMID: 30862072; PMCID: PMC6468654. https:\/\/doi.org\/10.3390\/biom9030095","DOI":"10.3390\/biom9030095"},{"issue":"8","key":"12935_CR16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.tips.2025.06.005","volume":"46","author":"F Buttgereit","year":"2025","unstructured":"Buttgereit F, Elling C, Jakob F (2025) Design and development of glucocorticoid receptor modulators. Trends Pharmacol Sci 46(8):771\u2013791","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"12935_CR17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1210\/endrev\/bnae008","volume":"45","author":"J Lockett","year":"2024","unstructured":"Lockett J, Inder WJ, Clifton VL (2024) The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity. Endocr Rev 45(4):593\u2013624","journal-title":"Endocr Rev"},{"key":"12935_CR18","doi-asserted-by":"crossref","unstructured":"Umberto Meduri G, Chrousos GP (2024) In: Fink G (ed) Chapter 22 - General adaptation in critical illness 1: The glucocorticoid signaling system as master rheostat of homeostatic corrections in concerted action with nuclear factor-\u03baB. Immunology and Inflammation: Academic, Stress, pp 231\u2013261","DOI":"10.1016\/B978-0-12-817558-3.00012-3"},{"issue":"Suppl 1","key":"12935_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40635-020-00325-z","volume":"8","author":"M Wepler","year":"2020","unstructured":"Wepler M, Preuss JM, Merz T, McCook O, Radermacher P, Tuckermann JP et al (2020) Impact of downstream effects of glucocorticoid receptor dysfunction on organ function in critical illness-associated systemic inflammation. Intensive Care Med Exp 8(Suppl 1):37","journal-title":"Intensive Care Med Exp"},{"issue":"3","key":"12935_CR20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jaci.2006.01.032","volume":"117","author":"K Ito","year":"2006","unstructured":"Ito K, Chung KF, Adcock IM (2006) Update on glucocorticoid action and resistance. J Allergy Clin Immunol 117(3):522\u2013543","journal-title":"J Allergy Clin Immunol"},{"key":"12935_CR21","doi-asserted-by":"publisher","unstructured":"Wadhwa R, Dua K, Adcock IM, Horvat JC, Kim RY, Hansbro PM. Cellular mechanisms underlying steroid-resistant asthma. Eur Respir Rev. 2019 Oct 21;28(153):190096. https:\/\/doi.org\/10.1183\/16000617.0096-2019","DOI":"10.1183\/16000617.0096-2019"},{"key":"12935_CR22","doi-asserted-by":"publisher","unstructured":"Timmermans S, Vandewalle J, Libert C. Dimerization of the Glucocorticoid Receptor and Its Importance in (Patho) physiology: A Primer. Cells. 2022 Feb 15;11(4):683. PMID: 35203332; PMCID: PMC8870481. https:\/\/doi.org\/10.3390\/cells11040683","DOI":"10.3390\/cells11040683"},{"issue":"1","key":"12935_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jaci.2007.09.010","volume":"121","author":"A Kelly","year":"2008","unstructured":"Kelly A, Bowen H, Jee Y-K, Mahfiche N, Soh C, Lee T et al (2008) The glucocorticoid receptor\u03b2 isoform can mediate transcriptional repression by recruiting histone deacetylases. J Allergy Clin Immunol 121(1):203\u20138e1","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"12935_CR24","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1042\/BST20210419","volume":"49","author":"F Frank","year":"2021","unstructured":"Frank F, Ortlund EA, Liu X (2021) Structural insights into glucocorticoid receptor function. Biochem Soc Trans 49(5):2333\u20132343","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"12935_CR25","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s10555-022-10047-1","volume":"41","author":"H Butz","year":"2022","unstructured":"Butz H, Pat\u00f3cs A (2022) Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression. Cancer Metastasis Rev 41(4):803\u2013832","journal-title":"Cancer Metastasis Rev"},{"key":"12935_CR26","doi-asserted-by":"publisher","first-page":"100687","DOI":"10.1016\/j.jbc.2021.100687","volume":"296","author":"AN Gerber","year":"2021","unstructured":"Gerber AN, Newton R, Sasse SK (2021) Repression of transcription by the glucocorticoid receptor: A parsimonious model for the genomics era. J Biol Chem 296:100687","journal-title":"J Biol Chem"},{"key":"12935_CR27","doi-asserted-by":"publisher","unstructured":"Timmermans S, Souffriau J, Libert C. A General Introduction to Glucocorticoid Biology. Front Immunol. 2019 Jul 4;10:1545. PMID: 31333672; PMCID: PMC6621919. https:\/\/doi.org\/10.3389\/fimmu.2019.01545","DOI":"10.3389\/fimmu.2019.01545"},{"issue":"4","key":"12935_CR28","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1172\/JCI88886","volume":"127","author":"SJ Desmet","year":"2017","unstructured":"Desmet SJ, De Bosscher K (2017) Glucocorticoid receptors: finding the middle ground. J Clin Invest 127(4):1136\u20131145","journal-title":"J Clin Invest"},{"issue":"2","key":"12935_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11882-008-0028-4","volume":"8","author":"IM Adcock","year":"2008","unstructured":"Adcock IM, Ford PA, Bhavsar P, Ahmad T, Chung KF (2008) Steroid resistance in asthma: Mechanisms and treatment options. Curr Allergy Asthma Rep 8(2):171\u2013178","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"12935_CR30","doi-asserted-by":"publisher","first-page":"e53936","DOI":"10.1371\/journal.pone.0053936","volume":"8","author":"EM King","year":"2013","unstructured":"King EM, Chivers JE, Rider CF, Minnich A, Giembycz MA, Newton R (2013) Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation- and transrepression-dependent mechanisms. PLoS ONE 8(1):e53936","journal-title":"PLoS ONE"},{"issue":"2","key":"12935_CR31","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1128\/MMBR.00064-15","volume":"80","author":"I Petta","year":"2016","unstructured":"Petta I, Dejager L, Ballegeer M, Lievens S, Tavernier J, De Bosscher K et al (2016) The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases. Microbiol Mol Biol Rev 80(2):495\u2013522","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"12935_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1189\/jlb.71.1.9","volume":"71","author":"WY Almawi","year":"2002","unstructured":"Almawi WY, Melemedjian OK (2002) Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J Leukoc Biol 71(1):9\u201315","journal-title":"J Leukoc Biol"},{"issue":"1","key":"12935_CR33","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.molcel.2012.10.013","volume":"49","author":"NH Uhlenhaut","year":"2013","unstructured":"Uhlenhaut NH, Barish GD, Yu RT, Downes M, Karunasiri M, Liddle C et al (2013) Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol Cell 49(1):158\u2013171","journal-title":"Mol Cell"},{"key":"12935_CR34","unstructured":"Nicolas Glucocorticoid Receptor: National Library of Medicine 2020. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279171\/"},{"issue":"1","key":"12935_CR35","doi-asserted-by":"publisher","first-page":"15440","DOI":"10.1038\/s41598-017-15549-5","volume":"7","author":"SH Khan","year":"2017","unstructured":"Khan SH, McLaughlin WA, Kumar R (2017) Site-specific phosphorylation regulates the structure and function of an intrinsically disordered domain of the glucocorticoid receptor. Sci Rep 7(1):15440","journal-title":"Sci Rep"},{"issue":"8","key":"12935_CR36","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1210\/me.2007-0219","volume":"22","author":"W Chen","year":"2008","unstructured":"Chen W, Dang T, Blind RD, Wang Z, Cavasotto CN, Hittelman AB et al (2008) Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol Endocrinol 22(8):1754\u20131766","journal-title":"Mol Endocrinol"},{"key":"12935_CR37","doi-asserted-by":"publisher","unstructured":"Niu Y, Liu C, Li P, Zhao J, Jin J, Yang J. Interleukin Networks in GVHD: Mechanistic Crosstalk, Therapeutic Targeting, and Emerging Paradigms. Int J Mol Sci. 2025 Sep 4;26(17):8620. PMID: 40943537; PMCID: PMC12429620. https:\/\/doi.org\/10.3390\/ijms26178620","DOI":"10.3390\/ijms26178620"},{"issue":"9674","key":"12935_CR38","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","volume":"373","author":"JL Ferrara","year":"2009","unstructured":"Ferrara JL, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet 373(9674):1550\u20131561","journal-title":"Lancet"},{"issue":"4","key":"12935_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.trsl.2007.06.003","volume":"150","author":"Y Sun","year":"2007","unstructured":"Sun Y, Tawara I, Toubai T, Reddy P (2007) Pathophysiology of acute graft-versus-host disease: recent advances. Transl Res 150(4):197\u2013214","journal-title":"Transl Res"},{"issue":"8","key":"12935_CR40","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1182\/blood.V90.8.3204","volume":"90","author":"GR Hill","year":"1997","unstructured":"Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL (1997) Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90(8):3204\u20133213","journal-title":"Blood"},{"issue":"1","key":"12935_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.iac.2009.10.001","volume":"30","author":"SW Choi","year":"2010","unstructured":"Choi SW, Levine JE, Ferrara JL (2010) Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin North Am 30(1):75\u2013101","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"12935_CR42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1182\/blood-2008-07-167098","volume":"113","author":"S Paczesny","year":"2009","unstructured":"Paczesny S, Krijanovski OI, Braun TM, Choi SW, Clouthier SG, Kuick R et al (2009) A biomarker panel for acute graft-versus-host disease. Blood 113(2):273\u2013278","journal-title":"Blood"},{"key":"12935_CR43","doi-asserted-by":"publisher","unstructured":"Ghimire S, Weber D, Mavin E, Wang XN, Dickinson AM, Holler E. Pathophysiology of GvHD and Other HSCT-Related Major Complications. Front Immunol. 2017 Mar 20;8:79. PMID: 28373870; PMCID: PMC5357769. https:\/\/doi.org\/10.3389\/fimmu.2017.00079","DOI":"10.3389\/fimmu.2017.00079"},{"issue":"4","key":"12935_CR44","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41385-022-00527-6","volume":"15","author":"SA Jansen","year":"2022","unstructured":"Jansen SA, Nieuwenhuis EES, Hanash AM, Lindemans CA (2022) Challenges and opportunities targeting mechanisms of epithelial injury and recovery in acute intestinal graft-versus-host disease. Mucosal Immunol 15(4):605\u2013619","journal-title":"Mucosal Immunol"},{"key":"12935_CR45","doi-asserted-by":"publisher","unstructured":"Jiang H, Fu D, Bidgoli A, Paczesny S. T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor. Front Immunol. 2021 Oct 5;12:761448. PMID: 34675938; PMCID: PMC8525316. https:\/\/doi.org\/10.3389\/fimmu.2021.761448","DOI":"10.3389\/fimmu.2021.761448"},{"key":"12935_CR46","doi-asserted-by":"publisher","first-page":"116652","DOI":"10.1016\/j.biopha.2024.116652","volume":"175","author":"Y Wang","year":"2024","unstructured":"Wang Y, Liu Q, Deng L, Ma X, Gong Y, Wang Y et al (2024) The roles of epigenetic regulation in graft-versus-host disease. Biomed Pharmacother 175:116652","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"12935_CR47","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1182\/blood.2019000952","volume":"136","author":"GR Hill","year":"2020","unstructured":"Hill GR, Koyama M (2020) Cytokines and costimulation in acute graft-versus-host disease. Blood 136(4):418\u2013428","journal-title":"Blood"},{"issue":"3","key":"12935_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12185-013-1421-x","volume":"98","author":"Y Maeda","year":"2013","unstructured":"Maeda Y (2013) Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses. Int J Hematol 98(3):293\u2013299","journal-title":"Int J Hematol"},{"issue":"6","key":"12935_CR49","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1182\/blood.V100.6.2216","volume":"100","author":"D Spaner","year":"2002","unstructured":"Spaner D, Sheng-Tanner X, Schuh AC (2002) Aberrant regulation of superantigen responses during T-cell reconstitution and graft-versus-host disease in immunodeficient mice. Blood 100(6):2216\u20132224","journal-title":"Blood"},{"issue":"1","key":"12935_CR50","first-page":"90","volume":"2","author":"S Kumar","year":"2017","unstructured":"Kumar S, Mohammadpour H, Cao X (2017) Targeting Cytokines in GVHD Therapy. J Immunol Res Ther 2(1):90\u201399","journal-title":"J Immunol Res Ther"},{"issue":"5","key":"12935_CR51","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1172\/JCI125797","volume":"129","author":"DN Fredricks","year":"2019","unstructured":"Fredricks DN (2019) The gut microbiota and graft-versus-host disease. J Clin Invest 129(5):1808\u20131817","journal-title":"J Clin Invest"},{"issue":"11","key":"12935_CR52","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","volume":"53","author":"HM Schoemans","year":"2018","unstructured":"Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR et al (2018) EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transpl 53(11):1401\u20131415","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"12935_CR53","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1164\/rccm.200512-1930OC","volume":"174","author":"M Hew","year":"2006","unstructured":"Hew M, Bhavsar P, Torrego A, Meah S, Khorasani N, Barnes PJ et al (2006) Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 174(2):134\u2013141","journal-title":"Am J Respir Crit Care Med"},{"key":"12935_CR54","doi-asserted-by":"publisher","first-page":"111277","DOI":"10.1016\/j.mce.2021.111277","volume":"530","author":"CS Martins","year":"2021","unstructured":"Martins CS, de Castro M (2021) Generalized and tissue specific glucocorticoid resistance. Mol Cell Endocrinol 530:111277","journal-title":"Mol Cell Endocrinol"},{"key":"12935_CR55","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12935-019-0940-9","volume":"19","author":"H Xiao","year":"2019","unstructured":"Xiao H, Ding Y, Gao Y, Wang LM, Wang H, Ding L et al (2019) Haploinsufficiency of NR3C1 drives glucocorticoid resistance in adult acute lymphoblastic leukemia cells by down-regulating the mitochondrial apoptosis axis, and is sensitive to Bcl-2 blockage. Cancer Cell Int 19:218","journal-title":"Cancer Cell Int"},{"issue":"3","key":"12935_CR56","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/bja\/aet077","volume":"111","author":"B Gibbison","year":"2013","unstructured":"Gibbison B, Angelini GD, Lightman SL (2013) Dynamic output and control of the hypothalamic-pituitary-adrenal axis in critical illness and major surgery. Br J Anaesth 111(3):347\u2013360","journal-title":"Br J Anaesth"},{"issue":"4","key":"12935_CR57","doi-asserted-by":"publisher","first-page":"R159","DOI":"10.1186\/ar3118","volume":"12","author":"MJ van Oosten","year":"2010","unstructured":"van Oosten MJ, Dolhain RJ, Koper JW, van Rossum EF, Emonts M, Han KH et al (2010) Polymorphisms in the glucocorticoid receptor gene that modulate glucocorticoid sensitivity are associated with rheumatoid arthritis. Arthritis Res Ther 12(4):R159","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"12935_CR58","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1210\/jc.2005-1107","volume":"90","author":"M den Brinker","year":"2005","unstructured":"den Brinker M, Joosten KFM, Liem O, de Jong FH, Hop WCJ, Hazelzet JA et al (2005) Adrenal Insufficiency in Meningococcal Sepsis: Bioavailable Cortisol Levels and Impact of Interleukin-6 Levels and Intubation with Etomidate on Adrenal Function and Mortality. J Clin Endocrinol Metabolism 90(9):5110\u20135117","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"12935_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2217\/pgs-2017-0084","volume":"19","author":"J Liu","year":"2018","unstructured":"Liu J, Wan Z, Song Q, Li Z, He Y, Tang Y et al (2018) NR3C1 gene polymorphisms are associated with steroid resistance in patients with primary nephrotic syndrome. Pharmacogenomics 19(1):45\u201360","journal-title":"Pharmacogenomics"},{"issue":"1","key":"12935_CR60","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1097\/HS9.0000000000000513","volume":"5","author":"JCG van der Zwet","year":"2021","unstructured":"van der Zwet JCG, Smits W, Buijs-Gladdines J, Pieters R, Meijerink JPP (2021) Recurrent NR3C1 Aberrations at First Diagnosis Relate to Steroid Resistance in Pediatric T-Cell Acute Lymphoblastic Leukemia Patients. Hemasphere 5(1):e513","journal-title":"Hemasphere"},{"issue":"1","key":"12935_CR61","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s44337-025-00191-2","volume":"2","author":"M Debes","year":"2025","unstructured":"Debes M, Elyasaky A, Elantary R, Abouzeid M (2025) Safety and efficacy of cellular therapy with mesenchymal stromal cells in sepsis, meta-analysis. Discover Med 2(1):17","journal-title":"Discover Med"},{"issue":"5","key":"12935_CR62","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s12185-011-0803-1","volume":"93","author":"JE Levine","year":"2011","unstructured":"Levine JE (2011) Implications of TNF-\u03b1 in the pathogenesis and management of GVHD. Int J Hematol 93(5):571\u2013577","journal-title":"Int J Hematol"},{"issue":"1","key":"12935_CR63","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, li J, Fu M, Zhao X, Wang W (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Therapy 6(1):402","journal-title":"Signal Transduct Target Therapy"},{"key":"12935_CR64","doi-asserted-by":"publisher","first-page":"760199","DOI":"10.3389\/fimmu.2021.760199","volume":"12","author":"LM Braun","year":"2021","unstructured":"Braun LM, Zeiser R (2021) Kinase Inhibition as Treatment for Acute and Chronic Graft-Versus-Host Disease. Front Immunol 12:760199","journal-title":"Front Immunol"},{"issue":"16","key":"12935_CR65","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1242\/dev.132340","volume":"143","author":"M La Fortezza","year":"2016","unstructured":"La Fortezza M, Schenk M, Cosolo A, Kolybaba A, Grass I, Classen A-K (2016) JAK\/STAT signalling mediates cell survival in response to tissue stress. Development 143(16):2907\u20132919","journal-title":"Development"},{"issue":"6","key":"12935_CR66","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1182\/blood.2020006075","volume":"136","author":"LK Meyer","year":"2020","unstructured":"Meyer LK, Verbist KC, Albeituni S, Scull BP, Bassett RC, Stroh AN et al (2020) JAK\/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation. Blood 136(6):657\u2013668","journal-title":"Blood"},{"issue":"12","key":"12935_CR67","doi-asserted-by":"publisher","first-page":"6865","DOI":"10.1073\/pnas.121455098","volume":"98","author":"JC Webster","year":"2001","unstructured":"Webster JC, Oakley RH, Jewell CM, Cidlowski JA (2001) Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci U S A 98(12):6865\u20136870","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12935_CR68","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.3389\/fimmu.2019.01438","volume":"10","author":"A Ahmed","year":"2019","unstructured":"Ahmed A, Schmidt C, Brunner T (2019) Extra-Adrenal Glucocorticoid Synthesis in the Intestinal Mucosa: Between Immune Homeostasis and Immune Escape. Front Immunol 10:1438","journal-title":"Front Immunol"},{"issue":"6","key":"12935_CR69","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1203\/01.pdr.0000219120.92049.b3","volume":"59","author":"ZH Aghai","year":"2006","unstructured":"Aghai ZH, Kumar S, Farhath S, Kumar MA, Saslow J, Nakhla T et al (2006) Dexamethasone Suppresses Expression of Nuclear Factor-kappaB in the Cells of Tracheobronchial Lavage Fluid in Premature Neonates with Respiratory Distress. Pediatr Res 59(6):811\u2013815","journal-title":"Pediatr Res"},{"key":"12935_CR70","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bbi.2014.12.024","volume":"46","author":"U Kuebler","year":"2015","unstructured":"Kuebler U, Zuccarella-Hackl C, Arpagaus A, Wolf JM, Farahmand F, von K\u00e4nel R et al (2015) Stress-induced modulation of NF-\u03baB activation, inflammation-associated gene expression, and cytokine levels in blood of healthy men. Brain Behav Immun 46:87\u201395","journal-title":"Brain Behav Immun"},{"issue":"12","key":"12935_CR71","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.bbmt.2009.08.003","volume":"15","author":"DR Couriel","year":"2009","unstructured":"Couriel DR, Saliba R, de Lima M, Giralt S, Andersson B, Khouri I et al (2009) A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease. Biol Blood Marrow Transpl 15(12):1555\u20131562","journal-title":"Biol Blood Marrow Transpl"},{"issue":"9","key":"12935_CR72","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.bbmt.2017.05.001","volume":"23","author":"FF Yalniz","year":"2017","unstructured":"Yalniz FF, Hefazi M, McCullough K, Litzow MR, Hogan WJ, Wolf R et al (2017) Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant 23(9):1478\u20131484","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"12935_CR73","doi-asserted-by":"publisher","first-page":"e0187184","DOI":"10.1371\/journal.pone.0187184","volume":"12","author":"CN De Jong","year":"2017","unstructured":"De Jong CN, Saes L, Klerk CPW, Van der Klift M, Cornelissen JJ, Broers AEC (2017) Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience. PLoS ONE 12(10):e0187184","journal-title":"PLoS ONE"},{"issue":"4","key":"12935_CR74","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1517\/14740338.2015.1009036","volume":"14","author":"G Murdaca","year":"2015","unstructured":"Murdaca G, Span\u00f2 F, Contatore M, Guastalla A, Penza E, Magnani O et al (2015) Infection risk associated with anti-TNF-\u03b1 agents: a review. Expert Opin Drug Saf 14(4):571\u2013582","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"12935_CR75","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/ajh.10392","volume":"74","author":"DA Jacobsohn","year":"2003","unstructured":"Jacobsohn DA, Hallick J, Anders V, McMillan S, Morris L, Vogelsang GB (2003) Infliximab for steroid-refractory acute GVHD: a case series. Am J Hematol 74(2):119\u2013124","journal-title":"Am J Hematol"},{"issue":"10","key":"12935_CR76","doi-asserted-by":"publisher","first-page":"5934","DOI":"10.4049\/jimmunol.169.10.5934","volume":"169","author":"E Goleva","year":"2002","unstructured":"Goleva E, Kisich KO, Leung DY (2002) A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. J Immunol 169(10):5934\u20135940","journal-title":"J Immunol"},{"key":"12935_CR77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cytogfr.2016.05.002","volume":"31","author":"J Banuelos","year":"2016","unstructured":"Banuelos J, Lu NZ (2016) A gradient of glucocorticoid sensitivity among helper T cell cytokines. Cytokine Growth Factor Rev 31:27\u201335","journal-title":"Cytokine Growth Factor Rev"},{"key":"12935_CR78","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-Gil A, Carrillo-Cruz E, Marrero-Cepeda C, Rodr\u00edguez G, P\u00e9rez-Sim\u00f3n JA. Effect of Vitamin D on Graft-versus-Host Disease. Biomedicines. 2022 Apr 24;10(5):987. PMID: 35625724; PMCID: PMC9138416. https:\/\/doi.org\/10.3390\/biomedicines10050987","DOI":"10.3390\/biomedicines10050987"},{"issue":"3","key":"12935_CR79","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1365-2567.2009.03244.x","volume":"130","author":"N Chetoui","year":"2010","unstructured":"Chetoui N, Boisvert M, Gendron S, Aoudjit F (2010) Interleukin-7 promotes the survival of human CD4\u2009+\u2009effector\/memory T cells by up-regulating Bcl-2 proteins and activating the JAK\/STAT signalling pathway. Immunology 130(3):418\u2013426","journal-title":"Immunology"},{"issue":"10","key":"12935_CR80","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/bmt.2010.300","volume":"46","author":"S Thiant","year":"2011","unstructured":"Thiant S, Labalette M, Trauet J, Coiteux V, de Berranger E, Dessaint JP et al (2011) Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD. Bone Marrow Transplant 46(10):1374\u20131381","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"12935_CR81","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1074-7613(00)80564-6","volume":"8","author":"X Zhang","year":"1998","unstructured":"Zhang X, Sun S, Hwang I, Tough DF, Sprent J (1998) Potent and Selective Stimulation of Memory-Phenotype CD8\u2009<\u2009sup>+\u2009T Cells In Vivo by IL-15. Immunity 8(5):591\u2013599","journal-title":"Immunity"},{"issue":"9","key":"12935_CR82","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1172\/JCI81261","volume":"125","author":"MJ Richer","year":"2015","unstructured":"Richer MJ, Pewe LL, Hancox LS, Hartwig SM, Varga SM, Harty JT (2015) Inflammatory IL-15 is required for optimal memory T cell responses. J Clin Invest 125(9):3477\u20133490","journal-title":"J Clin Invest"},{"issue":"1","key":"12935_CR83","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4049\/jimmunol.179.1.120","volume":"179","author":"MM Sandau","year":"2007","unstructured":"Sandau MM, Winstead CJ, Jameson SC (2007) IL-15 Is Required for Sustained Lymphopenia-Driven Proliferation and Accumulation of CD8 T Cells. J Immunol 179(1):120\u2013125","journal-title":"J Immunol"},{"issue":"1\u20132","key":"12935_CR84","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cellimm.2008.01.003","volume":"250","author":"CR Li","year":"2007","unstructured":"Li CR, Santoso S, Lo DD (2007) Quantitative analysis of T cell homeostatic proliferation. Cell Immunol 250(1\u20132):40\u201354","journal-title":"Cell Immunol"},{"issue":"2","key":"12935_CR85","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.20131271","volume":"211","author":"ER Mehlhop-Williams","year":"2014","unstructured":"Mehlhop-Williams ER, Bevan MJ (2014) Memory CD8\u2009+\u2009T cells exhibit increased antigen threshold requirements for recall proliferation. J Exp Med 211(2):345\u2013356","journal-title":"J Exp Med"},{"issue":"6","key":"12935_CR86","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1182\/blood-2008-06-162420","volume":"113","author":"MJ Carlson","year":"2009","unstructured":"Carlson MJ, West ML, Coghill JM, Panoskaltsis-Mortari A, Blazar BR, Serody JS (2009) In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood 113(6):1365\u20131374","journal-title":"Blood"},{"issue":"10","key":"12935_CR87","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1182\/blood-2008-08-175448","volume":"113","author":"R Das","year":"2009","unstructured":"Das R, Chen X, Komorowski R, Hessner MJ, Drobyski WR (2009) Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease. Blood 113(10):2352\u20132362","journal-title":"Blood"},{"key":"12935_CR88","doi-asserted-by":"crossref","unstructured":"DeFilipp Z, Alousi A, Levine JE, Holtan SG, Abedin S, Gooptu M et al (2026) Clinical Management of Acute Graft-Versus-Host Disease: An Evidence-Based Review from the ASTCT Committee on Practice Guidelines. Transplantation and Cellular Therapy","DOI":"10.1016\/j.jtct.2026.04.053"},{"key":"12935_CR89","unstructured":"Debes M (2021) Stem cells and regenerative medicine for congenital heart disease. University of Bristol"},{"key":"12935_CR90","unstructured":"Debes M (2021) Stem cells and regenerative medicine for congenital heart disease"},{"issue":"12","key":"12935_CR91","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1182\/blood-2017-11-815746","volume":"131","author":"JM Magenau","year":"2018","unstructured":"Magenau JM, Goldstein SC, Peltier D, Soiffer RJ, Braun T, Pawarode A et al (2018) \u03b1(1)-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease. Blood 131(12):1372\u20131379","journal-title":"Blood"},{"issue":"9","key":"12935_CR92","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.bbmt.2016.05.011","volume":"22","author":"AM Marcondes","year":"2016","unstructured":"Marcondes AM, Hockenbery D, Lesnikova M, Dinarello CA, Woolfrey A, Gernsheimer T et al (2016) Response of Steroid-Refractory Acute GVHD to \u03b11-Antitrypsin. Biol Blood Marrow Transpl 22(9):1596\u20131601","journal-title":"Biol Blood Marrow Transpl"},{"issue":"Supplement 1","key":"12935_CR93","doi-asserted-by":"publisher","first-page":"7747","DOI":"10.1182\/blood-2025-7747","volume":"146","author":"Y Wu","year":"2025","unstructured":"Wu Y, Zhong Z, Wang J, Zhu H, Mei H (2025) Effectiveness of belumosudil in acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT): A real-world observational study. Blood 146(Supplement 1):7747","journal-title":"Blood"},{"issue":"17","key":"12935_CR94","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1200\/JCO.20.02754","volume":"39","author":"M Jagasia","year":"2021","unstructured":"Jagasia M, Lazaryan A, Bachier CR, Salhotra A, Weisdorf DJ, Zoghi B et al (2021) ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease. J Clin Oncol 39(17):1888\u20131898","journal-title":"J Clin Oncol"},{"issue":"47","key":"12935_CR95","doi-asserted-by":"publisher","first-page":"16814","DOI":"10.1073\/pnas.1414189111","volume":"111","author":"A Zanin-Zhorov","year":"2014","unstructured":"Zanin-Zhorov A, Weiss JM, Nyuydzefe MS, Chen W, Scher JU, Mo R et al (2014) Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism. Proc Natl Acad Sci U S A 111(47):16814\u201316819","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"12935_CR96","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/ncomms1117","volume":"1","author":"M Saline","year":"2010","unstructured":"Saline M, R\u00f6dstr\u00f6m KEJ, Fischer G, Orekhov VY, Karlsson BG, Lindkvist-Petersson K (2010) The structure of superantigen complexed with TCR and MHC reveals novel insights into superantigenic T cell activation. Nat Commun 1(1):119","journal-title":"Nat Commun"},{"issue":"5","key":"12935_CR97","first-page":"725","volume":"14","author":"MS Jones","year":"1994","unstructured":"Jones MS, Riley R, Hamilton BL, Paupe J, Perez D, Levy RB (1994) Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma. Bone Marrow Transpl 14(5):725\u2013735","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"12935_CR98","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jdermsci.2018.11.010","volume":"92","author":"K Huang","year":"2018","unstructured":"Huang K, Ran L, Wang W, Zhou R, Cai X, Li R et al (2018) Glucocorticoid insensitivity by staphylococcal enterotoxin B in keratinocytes of allergic dermatitis is associated with impaired nuclear translocation of the Glucocorticoid Receptor \u03b1. J Dermatol Sci 92(3):272\u2013280","journal-title":"J Dermatol Sci"},{"key":"12935_CR99","doi-asserted-by":"publisher","first-page":"101767","DOI":"10.1016\/j.nexres.2026.101767","volume":"9","author":"M Dominik","year":"2026","unstructured":"Dominik M (2026) Inflammatory destabilization of glucocorticoid receptor signaling: A systems framework for glucocorticoid resistance. Next Res 9:101767","journal-title":"Next Res"},{"issue":"1","key":"12935_CR100","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/00007890-199701150-00018","volume":"63","author":"RA Hoffman","year":"1997","unstructured":"Hoffman RA, N\u00fcssler NC, Gleixner SL, Zhang G, Ford HR, Langrehr JM et al (1997) Attenuation of lethal graft-versus-host disease by inhibition of nitric oxide synthase. Transplantation 63(1):94\u2013100","journal-title":"Transplantation"},{"issue":"1","key":"12935_CR101","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1476-5381.2010.01199.x","volume":"163","author":"PJ Barnes","year":"2011","unstructured":"Barnes PJ (2011) Glucocorticosteroids: current and future directions. Br J Pharmacol 163(1):29\u201343","journal-title":"Br J Pharmacol"},{"issue":"1","key":"12935_CR102","doi-asserted-by":"publisher","first-page":"100005","DOI":"10.1016\/j.celld.2026.100005","volume":"2","author":"N Vijayan","year":"2026","unstructured":"Vijayan N, Rafiq AS, Annadurai B, Patel S (2026) The multifaceted role of cofilin in inflammation and pain signaling. Cell Death 2(1):100005","journal-title":"Cell Death"},{"issue":"22","key":"12935_CR103","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1182\/blood.2021012021","volume":"138","author":"C Cutler","year":"2021","unstructured":"Cutler C, Lee SJ, Arai S, Rotta M, Zoghi B, Lazaryan A et al (2021) Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study. Blood 138(22):2278\u20132289","journal-title":"Blood"},{"issue":"2\u20136","key":"12935_CR104","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1615\/CritRevImmunol.v37.i2-6.90","volume":"37","author":"T Calandra","year":"2017","unstructured":"Calandra T, Bucala R (2017) Macrophage Migration Inhibitory Factor (MIF): A Glucocorticoid Counter-Regulator within the Immune System. Crit Rev Immunol 37(2\u20136):359\u2013370","journal-title":"Crit Rev Immunol"},{"issue":"1","key":"12935_CR105","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1615\/CritRevImmunol.v17.i1.30","volume":"17","author":"T Calandra","year":"1997","unstructured":"Calandra T, Bucala R (1997) Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system. Crit Rev Immunol 17(1):77\u201388","journal-title":"Crit Rev Immunol"},{"key":"12935_CR106","doi-asserted-by":"publisher","unstructured":"Aharon A, Avni B, Louzoun D, Elias S, Stepensky P, Ram R, Zuckerman T, Meza-Romero R, Vandenbark AA, Grisariu S, Benedek G. MIF functional polymorphisms are associated with acute GVHD progression and steroid-refractoriness. Front Immunol. 2025 Apr 30;16:1504976. PMID: 40421032; PMCID: PMC12105047. https:\/\/doi.org\/10.3389\/fimmu.2025.1504976","DOI":"10.3389\/fimmu.2025.1504976"},{"key":"12935_CR107","doi-asserted-by":"publisher","unstructured":"Gupta S, Dutta S, Hui SP. Regenerative Potential of Injured Spinal Cord in the Light of Epigenetic Regulation and Modulation. Cells. 2023 Jun 22;12(13):1694. PMID: 37443728; PMCID: PMC10341208. https:\/\/doi.org\/10.3390\/cells12131694","DOI":"10.3390\/cells12131694"},{"issue":"1","key":"12935_CR108","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1084\/jem.20050466","volume":"203","author":"K Ito","year":"2006","unstructured":"Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ et al (2006) Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 203(1):7\u201313","journal-title":"J Exp Med"},{"issue":"20","key":"12935_CR109","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1101\/gad.1444606","volume":"20","author":"S Bilodeau","year":"2006","unstructured":"Bilodeau S, Vallette-Kasic S, Gauthier Y, Figarella-Branger D, Brue T, Berthelet F et al (2006) Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev 20(20):2871\u20132886","journal-title":"Genes Dev"},{"issue":"13","key":"12935_CR110","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1182\/bloodadvances.2021004225","volume":"5","author":"L Perez","year":"2021","unstructured":"Perez L, Fernandez H, Kharfan-Dabaja M, Khimani F, Betts B, Mishra A et al (2021) A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention. Blood Adv 5(13):2740\u20132750","journal-title":"Blood Adv"},{"issue":"5","key":"12935_CR111","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1073\/pnas.052702999","volume":"99","author":"F Leoni","year":"2002","unstructured":"Leoni F, Zaliani A, Bertolini G, Porro G, Pagani P, Pozzi P et al (2002) The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc Natl Acad Sci U S A 99(5):2995\u20133000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"12935_CR112","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/nm1652","volume":"13","author":"R Tao","year":"2007","unstructured":"Tao R, de Zoeten EF, \u00d6zkaynak E, Chen C, Wang L, Porrett PM et al (2007) Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 13(11):1299\u20131307","journal-title":"Nat Med"},{"issue":"11","key":"12935_CR113","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nm1107-1282","volume":"13","author":"P Reddy","year":"2007","unstructured":"Reddy P, Zou W (2007) Blocking HDACs boosts regulatory T cells. Nat Med 13(11):1282\u20131284","journal-title":"Nat Med"},{"issue":"8","key":"12935_CR114","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3390\/biomedicines13081807","volume":"13","author":"E Bretto","year":"2025","unstructured":"Bretto E, Urp\u00ec-Ferreruela M, Casanova GR, Gonz\u00e1lez-Su\u00e1rez B (2025) The Role of Gut Microbiota in Gastrointestinal Immune Homeostasis and Inflammation: Implications for Inflammatory Bowel Disease. Biomedicines 13(8):1807","journal-title":"Biomedicines"},{"issue":"3","key":"12935_CR115","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00018-018-2943-4","volume":"76","author":"A Adak","year":"2019","unstructured":"Adak A, Khan MR (2019) An insight into gut microbiota and its functionalities. Cell Mol Life Sci 76(3):473\u2013493","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"12935_CR116","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1016\/j.bbmt.2018.07.030","volume":"24","author":"LE Romick-Rosendale","year":"2018","unstructured":"Romick-Rosendale LE, Haslam DB, Lane A, Denson L, Lake K, Wilkey A et al (2018) Antibiotic Exposure and Reduced Short Chain Fatty Acid Production after Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant 24(12):2418\u20132424","journal-title":"Biol Blood Marrow Transplant"},{"key":"12935_CR117","first-page":"1","volume":"2015","author":"MS Debes","year":"2015","unstructured":"Debes MS (2015) Non Alcoholic Fatty Liver Overview. J Liver 2015:1\u20137","journal-title":"J Liver"},{"issue":"5","key":"12935_CR118","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ni.3400","volume":"17","author":"ND Mathewson","year":"2016","unstructured":"Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T et al (2016) Gut microbiome\u2013derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol 17(5):505\u2013513","journal-title":"Nat Immunol"},{"issue":"5","key":"12935_CR119","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s11427-020-1788-2","volume":"64","author":"Y Wang","year":"2021","unstructured":"Wang Y, Liu F, Zhang G, Su Y, Sun X, Chen Q et al (2021) Gut microbiome alterations and its link to corticosteroid resistance in immune thrombocytopenia. Sci China Life Sci 64(5):766\u2013783","journal-title":"Sci China Life Sci"},{"issue":"3","key":"12935_CR120","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5045\/br.2023.2023069","volume":"58","author":"HM Kim","year":"2023","unstructured":"Kim HM, Lee J, Kim S, Lee JW, Kim HJ, Cho YS (2023) Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease. Blood Res 58(3):145\u2013148","journal-title":"Blood Res"},{"issue":"5","key":"12935_CR121","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000492943","volume":"11","author":"F Noor","year":"2019","unstructured":"Noor F, Kaysen A, Wilmes P, Schneider JG (2019) The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials. J Innate Immun 11(5):405\u2013415","journal-title":"J Innate Immun"},{"issue":"16","key":"12935_CR122","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1182\/blood-2016-05-717652","volume":"128","author":"K Kakihana","year":"2016","unstructured":"Kakihana K, Fujioka Y, Suda W, Najima Y, Kuwata G, Sasajima S et al (2016) Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. Blood 128(16):2083\u20132088","journal-title":"Blood"},{"key":"12935_CR123","doi-asserted-by":"publisher","first-page":"678476","DOI":"10.3389\/fimmu.2021.678476","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Li X, Zhou Y, Gao J, Jiao Y, Zhu B et al (2021) Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial. Front Immunol 12:678476","journal-title":"Front Immunol"},{"issue":"7","key":"12935_CR124","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1182\/blood-2014-02-554725","volume":"124","author":"Y Taur","year":"2014","unstructured":"Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, Ling L et al (2014) The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 124(7):1174\u20131182","journal-title":"Blood"},{"issue":"9","key":"12935_CR125","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1900623","volume":"382","author":"JU Peled","year":"2020","unstructured":"Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD et al (2020) Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med 382(9):822\u2013834","journal-title":"N Engl J Med"},{"key":"12935_CR126","doi-asserted-by":"publisher","first-page":"946248","DOI":"10.3389\/fimmu.2022.946248","volume":"13","author":"A Christovich","year":"2022","unstructured":"Christovich A, Luo XM (2022) Gut Microbiota, Leaky Gut, and Autoimmune Diseases. Front Immunol 13:946248","journal-title":"Front Immunol"},{"key":"12935_CR127","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jnutbio.2015.09.020","volume":"27","author":"H Zhang","year":"2016","unstructured":"Zhang H, Du M, Yang Q, Zhu MJ (2016) Butyrate suppresses murine mast cell proliferation and cytokine production through inhibiting histone deacetylase. J Nutr Biochem 27:299\u2013306","journal-title":"J Nutr Biochem"},{"key":"12935_CR128","doi-asserted-by":"publisher","unstructured":"Qi X, Li X, Zhao Y, Wu X, Chen F, Ma X, Zhang F, Wu D. Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study. Front Immunol. 2018 Sep 25;9:2195. PMID: 30319644; PMCID: PMC6167440. https:\/\/doi.org\/10.3389\/fimmu.2018.02195","DOI":"10.3389\/fimmu.2018.02195"},{"issue":"6","key":"12935_CR129","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1182\/blood-2011-02-334821","volume":"118","author":"T Luft","year":"2011","unstructured":"Luft T, Dietrich S, Falk C, Conzelmann M, Hess M, Benner A et al (2011) Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system. Blood 118(6):1685\u20131692","journal-title":"Blood"},{"issue":"7","key":"12935_CR130","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.bbmt.2010.02.008","volume":"16","author":"M Palomo","year":"2010","unstructured":"Palomo M, Diaz-Ricart M, Carbo C, Rovira M, Fernandez-Aviles F, Martine C et al (2010) Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation. Biol Blood Marrow Transpl 16(7):985\u2013993","journal-title":"Biol Blood Marrow Transpl"},{"issue":"24","key":"12935_CR131","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1182\/blood-2008-10-161638","volume":"114","author":"A Shimabukuro-Vornhagen","year":"2009","unstructured":"Shimabukuro-Vornhagen A, Hallek MJ, Storb RF, von Bergwelt-Baildon MS (2009) The role of B cells in the pathogenesis of graft-versus-host disease. Blood 114(24):4919\u20134927","journal-title":"Blood"},{"issue":"7","key":"12935_CR132","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/DAD.0000000000000357","volume":"37","author":"A Fischer","year":"2015","unstructured":"Fischer A, Jakubowski AA, Lacouture ME, Hollmann TJ, Drucker AM, Maloy M et al (2015) Histopathologic Features of Cutaneous Acute Graft-Versus-Host Disease in T-Cell-Depleted Peripheral Blood Stem Cell Transplant Recipients. Am J Dermatopathol 37(7):523\u2013529","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"12935_CR133","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/ajcp\/aqw050","volume":"145","author":"M Salomao","year":"2016","unstructured":"Salomao M, Dorritie K, Mapara MY, Sepulveda A (2016) Histopathology of Graft-vs-Host Disease of Gastrointestinal Tract and Liver: An Update. Am J Clin Pathol 145(5):591\u2013603","journal-title":"Am J Clin Pathol"},{"key":"12935_CR134","doi-asserted-by":"publisher","unstructured":"Jiang Y, Tsoi LC, Billi AC, Ward NL, Harms PW, Zeng C, Maverakis E, Kahlenberg JM, Gudjonsson JE. Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin. JCI Insight. 2020 Oct 15;5(20):e142067. PMID: 33055429; PMCID: PMC7605526. https:\/\/doi.org\/10.1172\/jci.insight.142067","DOI":"10.1172\/jci.insight.142067"},{"issue":"3","key":"12935_CR135","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0301-472X(00)00677-9","volume":"29","author":"H Goker","year":"2001","unstructured":"Goker H, Haznedaroglu IC, Chao NJ (2001) Acute graft-vs-host disease: Pathobiology and management. Exp Hematol 29(3):259\u2013277","journal-title":"Exp Hematol"},{"issue":"4","key":"12935_CR136","doi-asserted-by":"publisher","first-page":"502","DOI":"10.37349\/ei.2024.00155","volume":"4","author":"RK Gupta","year":"2024","unstructured":"Gupta RK, Wasnik P, Mondal D, Shukla D (2024) Critical role of keratinocytes in cutaneous immune responses. Explor Immunol 4(4):502\u2013522","journal-title":"Explor Immunol"},{"key":"12935_CR137","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.humpath.2023.07.007","volume":"141","author":"AE Stueck","year":"2023","unstructured":"Stueck AE, Fiel MI (2023) Hepatic graft-versus-host disease: what we know, when to biopsy, and how to diagnose. Hum Pathol 141:170\u2013182","journal-title":"Hum Pathol"},{"issue":"13","key":"12935_CR138","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1182\/blood-2006-10-049817","volume":"110","author":"T Luft","year":"2007","unstructured":"Luft T, Conzelmann M, Benner A, Rieger M, Hess M, Strohhaecker U et al (2007) Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease. Blood 110(13):4535\u20134542","journal-title":"Blood"},{"issue":"8","key":"12935_CR139","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5500\/wjt.v11.i8.335","volume":"11","author":"M Nagasawa","year":"2021","unstructured":"Nagasawa M (2021) Biomarkers of graft-vs-host disease: Understanding and applications for the future. World J Transpl 11(8):335\u2013343","journal-title":"World J Transpl"},{"issue":"4","key":"12935_CR140","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.trim.2005.12.001","volume":"15","author":"S Nomura","year":"2006","unstructured":"Nomura S, Ishii K, Kanazawa S, Inami N, Kamitsuji Y, Uoshima N et al (2006) Role of platelet-derived chemokines (RANTES and ENA-78) after stem cell transplantation. Transpl Immunol 15(4):247\u2013253","journal-title":"Transpl Immunol"},{"issue":"4","key":"12935_CR141","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1182\/blood-2008-02-138867","volume":"112","author":"SW Choi","year":"2008","unstructured":"Choi SW, Kitko CL, Braun T, Paczesny S, Yanik G, Mineishi S et al (2008) Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Blood 112(4):1539\u20131542","journal-title":"Blood"},{"key":"12935_CR142","doi-asserted-by":"publisher","unstructured":"Akwii RG, Sajib MS, Zahra FT, Mikelis CM. Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology. Cells. 2019 May 17;8(5):471. PMID: 31108880; PMCID: PMC6562915. https:\/\/doi.org\/10.3390\/cells8050471","DOI":"10.3390\/cells8050471"},{"issue":"9","key":"12935_CR143","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.bbmt.2014.04.030","volume":"20","author":"N Ueda","year":"2014","unstructured":"Ueda N, Chihara D, Kohno A, Tatekawa S, Ozeki K, Watamoto K et al (2014) Predictive Value of Circulating Angiopoietin-2 for Endothelial Damage\u2013Related Complications in Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 20(9):1335\u20131340","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"12935_CR144","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nm1351","volume":"12","author":"U Fiedler","year":"2006","unstructured":"Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G et al (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-\u03b1 and has a crucial role in the induction of inflammation. Nat Med 12(2):235\u2013239","journal-title":"Nat Med"},{"issue":"10","key":"12935_CR145","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1136\/ard.2008.094664","volume":"68","author":"P K\u00fcmpers","year":"2009","unstructured":"K\u00fcmpers P, David S, Haubitz M, Hellpap J, Horn R, Br\u00f6cker V et al (2009) The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus. Ann Rheum Dis 68(10):1638\u20131643","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"12935_CR146","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbmt.2012.09.018","volume":"19","author":"S Dietrich","year":"2013","unstructured":"Dietrich S, Falk CS, Benner A, Karamustafa S, Hahn E, Andrulis M et al (2013) Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment. Biol Blood Marrow Transpl 19(1):22\u201327","journal-title":"Biol Blood Marrow Transpl"},{"issue":"25","key":"12935_CR147","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1182\/blood-2011-08-375006","volume":"118","author":"JL Ferrara","year":"2011","unstructured":"Ferrara JL, Harris AC, Greenson JK, Braun TM, Holler E, Teshima T et al (2011) Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. Blood 118(25):6702\u20136708","journal-title":"Blood"},{"issue":"3","key":"12935_CR148","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00277-021-04727-1","volume":"101","author":"J Yang","year":"2022","unstructured":"Yang J, Peng B, Wang L, Li X, Li F, Jin X et al (2022) Elevated REG3\u03b1 predicts refractory aGVHD in patients who received steroids-ruxolitinib as first-line therapy. Ann Hematol 101(3):621\u2013630","journal-title":"Ann Hematol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12935-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:02:27Z","timestamp":1792562547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12935-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12935"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12935-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"7 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AI was not used in this project.","order":1,"name":"Ethics","label":"AI use","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No relevant conflict of interest to declare.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1769"}}